Esophageal striated myogenesis progresses differently from appendicular myogenesis, but the mechanism underlying this process is incompletely understood. Early theories of transdifferentiation of smooth muscle into striated muscle are not supported by transgenic fate-mapping experiments; however, the origin of esophageal striated muscle remains unknown. To better define the process of striated myogenesis, we examined myogenesis in murine fetal cultured esophageal whole-organ explants. Embryonic day 14.5 (E14.5) esophagi maintained a functional contractile phenotype for up to 7 days in culture. Striated myogenesis, as evidenced by myogenin expression, proceeded in a craniocaudal direction along the length of the esophagus. Esophageal length did not change during this process. Complete, but not partial, mechanical disruption of the rostral esophagus inhibited myogenesis distally. Addition of fibroblast growth factor-2 (FGF-2) to the culture media failed to inhibit striated myogenesis, but attenuated smooth muscle actin expression and reduced peristaltic activity. Inhibition of c-kit failed to inhibit peristalsis. These results suggest that striated myogenic precursors are resident along the entire length of the esophagus by day 14.5 and do not migrate along the esophagus after E14.5. Induction of myogenesis craniocaudally appears to require physical continuity of the esophagus and is not inhibited by FGF-2. Finally, peristalsis in E14.5 esophagi appears not to be regulated by interstitial cells of Cajal.

Keywords:
Transdifferentiation, Smooth muscle actin, Organ culture
1.
Coffin, J.D., R.Z. Florkiewicz, J. Neumann, T. Mort-Hopkins, G.W. Dorn 2nd, P. Lightfoot, R. German, P.N. Howles, A. Kier, B.A. O’Toole (1995) Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell 6: 1861–1873.
2.
David, S.G., C. Cebrian, E.D. Vaughan Jr., D. Herzlinger (2005) c-kit and ureteral peristalsis. J Urol 173: 292–295.
3.
Jones, N.C., Y.V. Fedorov, R.S. Rosenthal, B.B. Olwin (2001) ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol 186: 104–115.
4.
Kablar, B., S. Tajbakhsh, M.A. Rudnicki (2000) Transdifferentiation of esophageal smooth to skeletal muscle is myogenic bHLH factor-dependent. Development 127: 1627–1639.
5.
Kato, S., A. Muraishi, T. Miyamoto, J.C. Fox (1998) Basic fibroblast growth factor regulates extracellular matrix and contractile protein expression independent of proliferation in vascular smooth muscle cells. In Vitro Cell Dev Biol Anim 34: 341–346.
6.
Kawai-Kowase, K., H. Sato, Y. Oyama, H. Kanai, M. Sato, H. Doi, M. Kurabayashi (2004) Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Arterioscler Thromb Vasc Biol 24: 1384–1390.
7.
Patapoutian, A., B.J. Wold, R.A. Wagner (1995) Evidence for developmentally programmed transdifferentiation in mouse esophageal muscle. Science 270: 1818–1821.
8.
Rishniw, M., P.W. Fisher, R.M. Doran, E. Meadows, W.H. Klein, M.I. Kotlikoff (2007) Smooth muscle persists in the muscularis externa of developing and adult mouse esophagus. J Muscle Res Cell Motil 28: 153–165.
9.
Rishniw, M., H.B. Xin, K.Y. Deng, M.I. Kotlikoff (2003) Skeletal myogenesis in the mouse esophagus does not occur through transdifferentiation. Genesis 36: 81–82.
10.
Stratton, C.J., Y. Bayguinov, K.M. Sanders, S.M. Ward (2000) Ultrastructural analysis of the transdifferentiation of smooth muscle to skeletal muscle in the murine esophagus. Cell Tissue Res 301: 283–298.
11.
Thyberg, J. (1996) Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 169: 183–265.
12.
Tortorella, L.L., D.J. Milasincic, P.F. Pilch (2001) Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J Biol Chem 276: 13709–13717.
13.
Weyman, C.M., A. Wolfman (1998) Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 139: 1794–1800.
14.
Wörl, J., W.L. Neuhuber (2005) Ultrastructural analysis of the smooth-to-striated transition zone in the developing mouse esophagus: emphasis on apoptosis of smooth and origin and differentiation of striated muscle cells. Dev Dyn 233: 964–982.
15.
Zhao, W., G.K. Dhoot (2000a) Both smooth and skeletal muscle precursors are present in foetal mouse oesophagus and they follow different differentiation pathways. Dev Dyn 218: 587–602.
16.
Zhao, W., G.K. Dhoot (2000b) Development and composition of skeletal muscle fibres in mouse oesophagus. J Muscle Res Cell Motil 21: 463–473.
17.
Zhao, W., G.K. Dhoot (2000c) Skeletal muscle precursors in mouse esophagus are determined during early fetal development. Dev Dyn 219: 10–20.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.